Perillyl alcohol suppresses antigen-induced immune responses in the lung

Area of Science:

• Immunology
• Pharmacology
• Respiratory Medicine

Background:

• Perillyl alcohol (POH) is an isoprenoid investigated for cancer treatment due to its inhibition of key enzymes in cell proliferation.
• While POH affects immunocyte proliferation, its impact on immune responses, particularly antigen-induced ones, remains under-explored.

Purpose of the Study:

• To investigate the effect of Perillyl alcohol (POH) on antigen-induced immune responses in a mouse model of allergic airway inflammation.
• To determine if POH can suppress allergic airway inflammation and associated immune cell activity.

Main Methods:

• A mouse model of allergic airway inflammation was established using ovalbumin (OVA) sensitization and aerosol challenge.
• Perillyl alcohol (POH) was administered to sensitized mice.
• Immune cell proliferation and cytokine production in spleen cells and CD4(+) T cells were assessed.
• Indicators of allergic airway inflammation, such as airway eosinophilia, and cytokine levels in thoracic lymph nodes were measured.

Main Results:

• POH treatment significantly suppressed the proliferation and cytokine production of antigen-stimulated spleen cells and CD4(+) T cells.
• POH administration markedly reduced indicators of allergic airway inflammation, including airway eosinophilia.
• Cytokine production in the thoracic lymph nodes of OVA-challenged mice was significantly suppressed by POH treatment.

Conclusions:

• Perillyl alcohol (POH) effectively suppresses antigen-induced immune responses in the lung.
• POH demonstrates potential as a novel preventive or therapeutic agent for immunologic lung disorders, such as asthma, with a favorable safety profile due to its natural origin.